PISCATAWAY, N.J. — Camber Pharmaceuticals on Wednesday announced the introduction of its generic of Boehringer Ingelheim’s Micardis (telmisartan) tablets. The drug is indicated to treat hypertension.
Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3×10 blister cards.
About Camber Pharmaceuticals
Through its parent company, Hetero Drugs of Hyderabad India, Camber is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.